Several private sector pharmacies have run out of the Glaxo-Smith-Kline drug 3TC, an anti-retroviral drug used in combination with others. Indications are that GSK is struggling to meet demand.

The health department has announced with great fanfare that it '€œmet its target'€ for the year with at least one anti-retroviral service point in each of the 53 districts.